Tag: Clinical trials

news-21062024-042224

New FDA-Approved Drug for Autoimmune Liver Disease: A Breakthrough Treatment

A breakthrough treatment for autoimmune liver disease has been approved by the U.S. Food and Drug Administration (FDA). The medication, Iqirvo (elafibranor), developed by...
news-19062024-210956

Revolutionizing Drug Development: The Impact of Artificial Intelligence

In a state-of-the-art laboratory at Terray Therapeutics in Monrovia, California, a groundbreaking revolution in drug development is taking place. The lab is a hub...
news-16062024-000230

New Title: FDA Advisory Panel Approves Experimental Alzheimer’s Drug: Promising Progress Ahead

An experimental Alzheimer’s drug called donanemab received approval from a U.S. Food and Drug Administration advisory panel. The drug is intended to treat early...
news-15062024-194504

FDA Panel Rejects MDMA-Assisted Therapies for PTSD Despite Veteran Support

Recently, a U.S. Food and Drug Administration (FDA) panel made a decision on MDMA-based treatments for post-traumatic stress disorder (PTSD), a treatment often used...
news-15062024-193931

Expert Panel Backs FDA Approval of New Alzheimer’s Drug

An expert panel recently gave its support for the FDA approval of a new drug for Alzheimer's disease called donanemab, manufactured by Eli Lilly....
news-14062024-182721

COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says COVID-flu combo vaccine...

A combination vaccine for COVID and influenza is showing promising results in phase 3 trials conducted by Moderna. The experimental vaccine, mRNA-1083, has demonstrated...
news-14062024-154444

Experimental Alzheimer’s drug receives FDA advisory panel’s approval: Progress is happeningSEO-friendly title: Alzheimer’s Drug...

An experimental Alzheimer's drug called donanemab received an endorsement from a U.S. Food and Drug Administration (FDA) advisory panel. The drug is intended to...
news-14062024-152207

Expert Panel Endorses FDA Approval of New Alzheimer’s Drug New Alzheimer’s Drug Receives Expert Panel...

An expert panel has given their endorsement to the FDA approval of a new drug for Alzheimer's disease. The drug, called donanemab and manufactured...

BREAKING NEWS

Top News